We are delighted to announce that we have secured investment from LYVA Labs and we welcome John Grumitt as our new non-executive director. The investment from LYVA Labs will support our expansion into the diabetic foot market. LYVA’s investments are focused on fostering healthcare innovation within the Liverpool City Region.
The addition of John Grumitt further strengthens the PelliTec team. John has an extensive network in diabetes health and brings a wealth of experience around scaling businesses.
Pictured above, the PelliTec team (Lenny, Jan, Peter and Karl) with Jon Grumitt, Non-Executive Director (second from the left).
To read more click here.
